John Paul Caesar Delos Trinos – Cost-effectiveness of mass drug administration for intestinal worm control

A spotlight on Global Health: Learn about research and programs aimed at improving health outcomes in areas of need through collaborations in low- and middle-income countries.

School-based targeted preventive chemotherapy, the main control strategy for intestinal worms, excludes adults. Mass drug administration would benefit the entire population but requires greater investment. Utilising cost surveys, systematic review, and economic modelling, this thesis evaluated the cost, effectiveness, and cost-effectiveness of mass drug administration compared with school-based targeted preventive chemotherapy for intestinal worm control in Vietnam and the Philippines.

John Paul Caesar Delos Trinos Chief Scientific Officer, metaHealth and Scientia PhD Student, Global Health Program, Kirby Institute Paul is the chief scientific officer of metaHealth Insights and Innovations; a Philippine consulting firm focused on economic evaluation, management, technology assessment, and analytics for health. He is also a guest professorial lecturer at the De La Salle Health Science Institute, where he teaches health economics and HTA. He is pursuing his PhD in the Global Health Program at the Kirby Institute, examining the cost-effectiveness of preventive chemotherapy for soil-transmitted helminth control.

Opinions expressed by individuals at this event are solely of those of the individual/s and do not necessarily represent the views or opinions of the Kirby Institute or UNSW.